ENDRA Life Sciences Inc.

NDRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.31

+$0.81 (+14.73%)

At close: Sep 21, 2026, 4:00 PM ET

$6.38

+$0.07 (+1.09%)

Pre-market: Sep 22, 2026, 7:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $8.01M

Enterprise Value $6.7M

Beta -0.07

Average Volume 32.04K

Shares Outstanding (Diluted) 2.48M

Shares Change YoY 245.17%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US29273B5003

Price Performance

Price Change 1M 38.1%

Price Change 3M 18.8%

Price Change 6M 68.3%

Price Change YTD 47.1%

Price Change 1Y 31.2%

Price Change 3Y -99.7%

Price Change 5Y -100.0%

1M CAGR (ann.) 37.2%

1Y CAGR (ann.) 31.5%

5Y CAGR (ann.) -84.2%

All-Time CAGR -66.1%

Valuation

PE Ratio -0.99

Forward PE N/A

PEG Ratio -0.01

Forward PEG 0.07

PS Ratio N/A

Forward PS 40.10

PB Ratio 1.27

P/FCF Ratio -1.00

P/Adj. FCF Ratio -0.91

P/OCF Ratio -1.73

EV/Sales N/A

EV/EBIT -1.10

EV/EBITDA -1.13

EV/FCF -0.84

Earnings Yield -101.3%

FCF Yield -99.9%

Adj. FCF Yield -110.2%

Financial Health

Net Cash $1.31M

Total Debt $429.27K

Cash & Short-Term Investments $1.74M

Total Assets $7.94M

Current Ratio 7.10

Quick Ratio 7.10

Debt / Equity Ratio 0.07

Debt / EBITDA -0.07

Debt / FCF -0.05

OCF / Debt -11.67

Interest Coverage 0.00

Altman Z-Score -18.53

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -10.3%

Returns

Return on Assets -74.5%

Return on Equity -224.8%

Return on Invested Capital -91.2%

Return on Capital Employed -92.9%

Return on Tangible Assets -74.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -50.4%

EPS CAGR 3Y -4.6%

EPS CAGR 5Y 100.0%

EPS CAGR 10Y -6.1%

FCF CAGR 3Y 7.6%

FCF CAGR 5Y 13.2%

FCF CAGR 10Y -6.0%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.84

EPS Growth Est (next Q) -52.0%

Revenue Est (next Q) $100K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25

Price Target Upside 296.2%

Cash Flow

Operating Cash Flow $-5.01M

Free Cash Flow $-8.01M

Adj. Free Cash Flow $-8.83M

FCF Per Share -$5.92

OCF Per Share -$3.64

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-39.72K

Operating Income $-5.17M

EBITDA $-5.96M

Net Income $-5.92M

EPS (Diluted) -$6.39

Revenue / Employee N/A

Profit / Employee $-591.67K

Employees 10